Research output per year
Research output per year
Organisation profile
Organisation profile
The PMBRC (www.pmbrc.org) has established itself as a leading research centre in the pharmaceutical, chemical and biological sciences in Ireland. Situated on the main WIT campus, the centre has an innovative research programme spanning drug delivery, molecular biology, solid state pharmaceutical science, analytical science, biosensor development and biomedical science. One of 16 Enterprise Ireland-funded Technology Gateways, the PMBRC supports R&D activities of a wide range of industries including the pharma, med tech, engineering and agri-food sectors. A truly multidisciplinary team, researchers in the PMBRC include chemists, biologists, biomedical scientists, physicists and engineers, and the centre has established links with national and international partners across industry and academia. The PMBRC was named Pharma Research Centre of the Year at the 2020 Pharma Industry Awards, having previously won the Research and Development Achievement awards in 2019 and 2017.
UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. Our work contributes towards the following SDG(s):
Fingerprint
Dive into the research topics where Pharmaceutical and Molecular Biotechnology Research Centre is active. These topic labels come from the works of this organisation's members. Together they form a unique fingerprint.
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Profiles
-
Dr Mitra Abedini
- Department of Science - Development Scientist
- Pharmaceutical and Molecular Biotechnology Research Centre
Person: Nonacademic
-
Controlled release of naringenin from soft hydrogel contact lens: An investigation into lens critical properties and in vitro release
(Chau Thuy) Nguyen, D., Dowling, J., Ryan, R., McLoughlin, P. & Fitzhenry, L., 01 Jun 2022, In: International Journal of Pharmaceutics. 621, p. 121793 121793.Research output: Contribution to journal › Article › peer-review
Open Access2 Citations (Scopus) -
COVID-19: Outbreak, Advancements and Possibilities
Syed, A. F., 15 Feb 2022, In: International Journal of Biosciences.Research output: Contribution to journal › Article › peer-review
-
Developing ciprofloxacin dry powder for inhalation: A story of challenges and rational design in the treatment of cystic fibrosis lung infection: A story of challenges and rational design in the treatment of cystic fibrosis lung infection
Al-Hajj, N., O'Reilly, N. & Fox, H., 05 Feb 2022, In: International Journal of Pharmaceutics. 613, 121388.Research output: Contribution to journal › Review article › peer-review
2 Citations (Scopus)
Prizes
-
ACM NanoCoCoA 2020 Best Paper Award:
Martins, Daniel P. (Recipient), Quach O'Reilly, Huong (Recipient), Coffey, Lee V. (Recipient), Cotter, Paul (Recipient) & Balasubramaniam, Sasitharan (Recipient), 16 Nov 2020
Prize: Honorary award
-
-